Proud moment: our Central Compound Management team has won the Platinum Award at the 12th CII National Kaizen Circle Competition 2026.
By automating Assay Ready Plate creation, plate-map generation is now 93% faster with 100% error-free data.
#DrugDiscovery#CRDMO
A Phase II molecule with promising science and a process not ready to scale.
Our team optimized it end to end: yield up from 35% to 54%, greener solvents, two stages into one pot.
Higher ROI, smaller footprint, faster route to commercial.
#GreenChemistry#CDMO
The move from preclinical promise to clinical proof is where programs are tested.
Our new Clinical Translational Sciences Lab brings biomarkers into trial workflows with high-quality samples, so clients see sooner which programs to move forward.
#Biomarkers#ClinicalDevelopment
Thrilled to welcome Sreenivasulu Bandaru to Syngene as Head of Chemical Development, Small Molecule CDMO.
24+ years of experience, 350+ customer projects, and collaborations with 10+ global pharma leaders, bringing deep expertise from route scouting to CMC.
#Growth#Leadership
Sustainability vs operational excellence?
At Syngene, we do both.
At Mangaluru, 31 API clean-room areas now run on recovered waste heat, not steam.
Steam demand down nearly 49%, cooling loads down 240 TR/day.
Compliant capacity, delivered the sustainable way.
#Sustainability
New at Syngene: a HPAPI Analytical Laboratory built for the next generation of high-potency therapies.
Advanced containment that protects your people and product, faster lab-to-lab transfer, and capacity for the work others hesitate to touch.
#HPAPI#CRDMO#PharmaInnovation
At Syngene's Discovery Chemistry Operations, Lean Six Sigma projects, from same-day raw material ordering to live shipment tracking, are reducing delays and giving clients greater certainty on timelines and molecules.
#Syngene#OperationalExcellence#LeanSixSigma
Our Clinical Research Associates and cross-functional teams came together for an immersive workshop on ICH E6 (R3), ALCOA+, risk-based monitoring, and inspection readiness.
Building capability from within, so sponsor programmes keep moving when it matters most.
#Syngene#GCP
Congratulations to Dr. Shailesh Biradar, recognised as a 'Rising Star' at the FDD Leadership Awards 2026 for his work in oral and parenteral drug product development.
Our clients' molecules are in the hands of some of the most respected minds in formulation.
#Syngene
Every hour saved in the lab is an hour returned to your molecule.
Our new on-site solvent dispensing station at Biocon Park, Bengaluru has cut dispensing time by 80%+, helping teams move faster, reduce delays, and keep client programs on track.
#Syngene#CRDMO
A big welcome to Vishwanath Krishnamurthy, joining Syngene as Head of Manufacturing Operations, Biologics.
With 26+ years of experience in biologics manufacturing, he brings deep expertise in scale-up, technology transfer and operational excellence.
#Biologics
We're pleased to welcome Siddharth Mittal as Managing Director and CEO of Syngene.
He joins us from Biocon, bringing nearly three decades of leadership across finance, strategy and commercial operations.
Welcome aboard, Siddharth. We look forward to the journey ahead.
#Syngene
THANK YOU NOTE π
We extend our sincere gratitude to esteemed panelists & delegates for their participation and support at our e-Conference,Β 'The Future of #ClinicalResearch in India: Can India Become a Global Trial Hub?' onΒ 19 June 2026.
Watch Now: https://t.co/2DXsSxvMSs
Come see what we've built!
Dr. Rohtash Kumar invites you inside Syngene's new ADC GMP facility.
Chemistry, bioconjugation, analytical, and GMP manufacturing.
All under one roof.
We'd love to have you over.
Book a visit: https://t.co/lSRmojwsu2
#ADC#CDMO#Syngene
A 360Β° look at Booth #4907.
Conversations on next-gen therapies, ADCs, and what comes next in drug development.
BIO 2026 is over. The momentum isnβt.
#BIO2026#CRDMO#DrugDiscovery
The stork is staying perched at Booth #4907 at BIO 2026.
Day 2 went deeper into conversations shaping biopharma.
Dr. Rohtash Kumar spoke on value over volume and scaling globally while managing costs.
Clear signal: partners are chosen for intent and agility.
#BIO2026#CRDMO
Syngene is now the only Indian pharma and biotech company with the JUSE-QCFI 5S certification, jointly awarded by Quality Circle Forum of India and Union of Japanese Scientists and Engineers.
Two more units certified.
Total now: 4.
#OperationalExcellence#5S#Syngene
ADCs are changing what's possible for patients.
A week since we inaugurated our new GMP bioconjugation facility for cytotoxic payloads. Syngene now offers end-to-end ADC capabilities, from discovery to GMP manufacturing.
Hear from Dr. Jayashree Aiyar, CSO.
#ADC#Bioconjugation
The Syngene Stork has settled in at #BIO2026.
Day 1 brought sharper questions, real conversations, and a reminder of what it means to carry a molecule with care.
Come say hello at Booth #4907, Hall F.
#SyngeneStork#CRDMO#DrugDiscovery
400+ students.
5 government schools.
From testing the pH of their own water to planting saplings, children explored health, environment, and small choices that shape the future.
Somewhere in those classrooms, a future changemaker was listening.
#Sustainability#CSR#Education